ESPR
Esperion Therapeutics Inc.
Company Overview
| Mkt Cap | $536.32M | Price | $2.97 |
| Volume | 6.29M | Change | +4.58% |
| P/E Ratio | -10.4 | Open | $2.84 |
| Revenue | $332.3M | Prev Close | $2.84 |
| Net Income | $-51.7M | 52W Range | $0.69 - $3.94 |
| Div Yield | N/A | Target | $6.09 |
| Overall | 54 | Value | 40 |
| Quality | 44 | Technical | 80 |
No chart data available
Stock Overview
Updated DailyEsperion Therapeutics Inc. (ESPR) is a leading Healthcare company in the Biotechnology industry, currently trading at $2.97 with a market capitalization of $536.32 million. The stock is positioned in the upper portion of its trading range, demonstrating below-average quality metrics with a MarketXLS quality score of 44.
Today's trading session shows ESPR with a volume of 6.29 million shares. The stock opened down 0.00% from yesterday's close of $2.84. Current analyst estimates project earnings of $-0.05 per share for this year, with next year targeting $0.07.
ESPR demonstrates very strong technical momentum based on technical analysis. The company trades on the NSD exchange and operates alongside industry peers including RARE, BMRN, FOLD, LXRX, PFE.
Key investment considerations for ESPR include average overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 105.1%. The stock shows elevated valuation levels based on valuation analysis.
Analysis generated on November 3, 2025 at 07:37 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ESPR | $2.97 | +4.6% | 6.29M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Esperion Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW